BlossomHill Therapeutics, Inc. (BLSM) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$26.80

From 52W high−4.03%

Volume715109.00

Market cap$788.77M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$26.80

From 52W high

−4.03%

Volume

715109.00

Market cap

$788.77M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.9x

P/E (TTM)

—

RSI (14)

79.5

MomentumView details →

1D Return

−4.03%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−10.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−5.2x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

39.81%

ROA (TTM)

−42.23%

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−96.23%

EBITDA YoY

—

MomentumView details →

1D Return

−4.03%

YTD Return

—

1Y Return

—

RSI (14)

79.5

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

−0.15x

Current Ratio

7.40x

Quick Ratio

7.40x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.84

EPS Surprise

9.83%

Beats (12Q)

1/12

Next Q EPS Est

−$0.87

Avg Surprise (4Q)

9.83%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for BLSM.

Similar companies

Gyre Therapeutics, Inc.GYRE DBV Technologies S.A.DBVT Annexon, Inc.ANNX Climb Bio, Inc.CLYM Design Therapeutics, Inc.DSGN Achieve Life Sciences, Inc.ACHV Find similar companies →

Latest newsMore news →

No recent news for BLSM.